Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9501
iShares Future Exponential Technologies ETF
XT
$3.99B
| $329K | ﹤0.01% |
6,861
-23,305
| -77% | -$1.21M |
|
|
SFRWW
9502
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
| $329K | ﹤0.01% |
1,643,397
-160,785
| -9% | -$38.4K |
|
9503
PUT
Advanced Energy
AEIS
$13.2B
| $328K | ﹤0.01% |
4,500
-3,200
| -42% | -$247K |
|
9504
Arlo Technologies
ARLO
$1.54B
| $328K | ﹤0.01% |
52,324
-101,226
| -66% | -$740K |
|
9505
CALL
Brink's
BCO
$4.71B
| $328K | ﹤0.01% |
5,400
-19,400
| -78% | -$1.17M |
|
9506
CALL
Vertical Aerospace
EVTL
$142M
| $328K | ﹤0.01% |
10,400
-1,140
| -10% | -$68.6K |
|
9507
Incyte
INCY
$24.4B
| $328K | ﹤0.01% |
4,323
-1,106,259
| -100% | -$84M |
|
|
JRE
9508
DELISTED
Janus Henderson US Real Estate ETF
JRE
| $328K | ﹤0.01% |
14,236
+2,300
| +19% | +$58.1K |
|
9509
PLAYSTUDIOS Inc
MYPS
$63.1M
| $328K | ﹤0.01% |
76,597
-105,249
| -58% | -$572K |
|
9510
CALL
Red Robin
RRGB
$192M
| $328K | ﹤0.01% |
40,900
-19,100
| -32% | -$206K |
|
9511
CALL
Banco Santander Chile
BSAC
$16.3B
| $327K | ﹤0.01% |
+20,100
| New | +$391K |
|
9512
PUT
Beazer Homes USA
BZH
$872M
| $327K | ﹤0.01% |
27,100
-4,100
| -13% | -$59.9K |
|
9513
Polaris
PII
$3.95B
| $327K | ﹤0.01% |
3,288
-95,259
| -97% | -$9.87M |
|
9514
CALL
Direxion Daily Transportation Bull 3X ETF
TPOR
$21.2M
| $327K | ﹤0.01% |
14,100
+3,800
| +37% | +$119K |
|
|
IEA
9515
CALL
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $327K | ﹤0.01% |
40,700
-9,900
| -20% | -$92.6K |
|
|
MTOR
9516
CALL
DELISTED
MERITOR, Inc.
MTOR
| $327K | ﹤0.01% |
9,000
-12,800
| -59% | -$460K |
|
9517
PUT
Altimmune
ALT
$572M
| $326K | ﹤0.01% |
27,900
-4,200
| -13% | -$25.9K |
|
9518
Krispy Kreme
DNUT
$578M
| $326K | ﹤0.01% |
23,974
-105,817
| -82% | -$1.46M |
|
9519
Middlesex Water
MSEX
$1.11B
| $326K | ﹤0.01% |
+3,712
| New | +$333K |
|
9520
PUT
PDS Biotechnology
PDSB
$12.9M
| $326K | ﹤0.01% |
89,400
+64,200
| +255% | +$305K |
|
9521
2x Long VIX Futures ETF
UVIX
$211M
| $326K | ﹤0.01% |
+2
| New | +$372K |
|
|
CUTR
9522
CALL
DELISTED
Cutera, Inc.
CUTR
| $326K | ﹤0.01% |
8,700
-12,700
| -59% | -$670K |
|
|
SILV
9523
CALL
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $326K | ﹤0.01% |
53,400
-16,400
| -23% | -$124K |
|
|
ROOF
9524
DELISTED
NYLI CBRE NextGen Real Estate ETF
ROOF
| $326K | ﹤0.01% |
15,420
-5,161
| -25% | -$122K |
|
|
ASCBU
9525
DELISTED
A SPAC II Acquisition Corp. Unit
ASCBU
| $326K | ﹤0.01% |
+32,528
| New | +$324K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.